Telomere Length and Cancer

Telomeres, the protective caps at the ends of human chromosomes, shorten with each round of cell division, representing a counter in the form of a biological clock. Beyond 50 to 60 divisions, the protective function of the telomeres will become unsustainable, and cells will usually experience senescence and death. Loss of cell function is manifested in the form of aging and the onset of diseases, including cancer. Cancer cells have found a way around this by overexpressing an enzyme, called telomerase, which counteracts the telomere shortening, thus allowing the neoplastic cells to keep replicating. This narrative review outlines why telomeres undergo shortening and how cancer cells exploit and take advantage of that phenomenon. The fact that malignant cells derail the biological telomere clock could be targeted for therapeutic benefit. The review also highlights the diverse telomere-based strategies explored in cancer treatment.

Authors

Institutions

Publication Details

Journal
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
Published
2025-01-09
DOI
https://doi.org/10.54133/ajms.v8i1.1615
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Telomere Length and Cancer

Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
Telomeres, Telomerase, and Senescence
article

Telomere Length and Cancer

Ismail Ibrahim Al-Janabi
article en

Abstract

Telomeres, the protective caps at the ends of human chromosomes, shorten with each round of cell division, representing a counter in the form of a biological clock. Beyond 50 to 60 divisions, the protective function of the telomeres will become unsustainable, and cells will usually experience senescence and death. Loss of cell function is manifested in the form of aging and the onset of diseases, including cancer. Cancer cells have found a way around this by overexpressing an enzyme, called telomerase, which counteracts the telomere shortening, thus allowing the neoplastic cells to keep replicating. This narrative review outlines why telomeres undergo shortening and how cancer cells exploit and take advantage of that phenomenon. The fact that malignant cells derail the biological telomere clock could be targeted for therapeutic benefit. The review also highlights the diverse telomere-based strategies explored in cancer treatment.

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )Vol. 8(1)
Epsom Hospital (GB)
Good health and well-being
Openalex Percentile: Top 99%
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Telomere Length and Cancer — Ismail Ibrahim Al-Janabi · Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2025) | TGRS Research Map | TGRS